 Home > Active Ingredient News > Immunology News > NEJM: How effective is Pesolizumab in treating systemic pustular psoriasis?

NEJM: How effective is Pesolizumab in treating systemic pustular psoriasis?

 Last Update: 2021-12-24
 Source: Internet
 Author: User

Tags

4 point probe

1 8 channel

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Systemic pustular psoriasis (GPP) is a rare, life-threatening inflammatory skin disease characterized by widespread outbreaks of sterile pustules

Recently, a research article was published in the top medical journal NEJM.

The primary end point of the study was the Generalized Pustular Psoriasis Physician’s Global Assessment (GPPGA) pustule score of 0 (range 0 [no visible pustules] to 4 [severe pustules] at the first week after treatment )

A total of 53 patients were recruited for the study: 35 were assigned to receive pesolizumab, and 18 were assigned to receive placebo

Infect

In this phase 2 randomized trial involving GPP patients, the interleukin-36 receptor inhibitor pesolimab had a higher clearance rate than placebo at 1 week, but it was related to infection and systemic drug reactions

The interleukin 36 receptor inhibitor Pesolizumab had a higher lesion clearance rate than placebo at 1 week, but it was related to infection and systemic drug reactions

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Top Quality 99.9% Ritlecitinib Tosylate Immunoregulation API & Inflammation Inhibitor

CAS No.: 2192215-81-7

Pharmacy Grade; Food Grade

$200-250/G FOB

β-Alanine107-95-9

CAS No.: 107-95-9

$1-1.1/KG FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.